This article is more than 5 years old. Information may no longer be current.

InVivo Therapeutics announces regulatory, clinical promotions

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

InVivo Therapeutics Holdings Corp. announced the promotion of Lisa Crockett to vice president, regulatory, and Kristin Neff to vice president, clinical operations.

“These two executives have been instrumental in our effort to put our first product candidate into the clinic in the next few months,” Michael Astrue, interim chief executive officer, stated in a press release. “They have both also demonstrated expertise and judgment with their work on InVivo’s evolving pipeline.”

InVivo Therapeutics, in Cambridge, Mass., is a medical device company founded to develop and commercialize groundbreaking technologies for the treatment of spinal cord injuries.